[The influence of verapamil on platelet function in patients with multiple myeloma].
作者信息
Sokołowska B, Dmoszyńska A, Walter-Croneck A, Wojtaszko M
机构信息
Kliniki Hematologii Akademii Medycznej w Lublinie.
出版信息
Pol Merkur Lekarski. 1997 Feb;2(8):109-10.
PMID:9538652
Abstract
Influence of verapamil on platelet function was evaluated in 7 female and 8 male patients with myeloma. The inhibitory effect on platelet aggregation and other parameters was documented in clinical observation.
摘要
相似文献
1
[The influence of verapamil on platelet function in patients with multiple myeloma].
Pol Merkur Lekarski. 1997 Feb;2(8):109-10.
2
[Chemotherapy of multiple myeloma].
Sov Med. 1991(3):43-6.
3
[Pneumonia caused by Salmonella in a patient with myeloma].
Sangre (Barc). 1995 Jun;40(3):234-5.
4
[Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
Rev Clin Esp. 1985 May;176(8):392-5.
5
[Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
Sangre (Barc). 1984;29(6):993-9.
6
Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Ann Hematol. 2007 Dec;86(12):919-21. doi: 10.1007/s00277-007-0331-5. Epub 2007 Jul 20.
7
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
Cancer Treat Rep. 1984 Dec;68(12):1439-46.
8
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
Bone Marrow Transplant. 1989 Jan;4 Suppl 1:168-9.
9
Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Arch Immunol Ther Exp (Warsz). 1981;29(2):145-53.
10
[Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].
Sangre (Barc). 1991 Oct;36(5):434-5.
Zotero 插件